abstract |
Compounds of formula (1) are described wherein: R is hydrogen or -C(O)-(CH2)m-Q, wherein Q is hydrogen or -COOH and m is an integer 1, 2, 3 or 4; R1, R5 and R6 are independently a C1-C6 alkyl group; R2, R3 and R4 are independently hydrogen or a C1-C6 alkyl group; Z is thio, oxy or a methylene group; A is a C1-C4 alkylene group; X is thio or oxy; and G1 and G2 are independently hydrogen, C1-C6 alkyl or -C(O)-(CH2)n-CH3 an n is an integer 0, 1, 2 or 3; or a pharmaceutically acceptable salt thereof; useful for the treatment of atherosclerosis and chronic inflammatory disorders; for inhibiting cytokine-induced expression of VCAM-1 and/or ICAM-1; for inhibiting the peroxidation of LDL lipid; for lowering plasma cholesterol; and as anti-oxidant chemical additives useful for preventing oxidative deterioration in organic materials. The use of the compounds for treating chronic inflammatory diseases such as asthma, rheumatoid arthritis, autoimmune diabetes, transplant rejection, and tumour angiogenesis is also described. |